Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Aversa

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Bone Marrow Transplantation|February 16, 1999
Mismatched T cell-depleted hematopoietic stem cell transplantation for children with high-risk acute leukemiaF Aversa, A Terenzi, R Felicini, et al.
The New England Journal of Medicine|October 22, 1998
Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotypeF Aversa, A Tabilio, A Velardi, et al.
The Italian Journal of Gastroenterology|May 1, 1996
Effect of ursodeoxycholic acid on hypertransaminasaemia and bile acid composition in patients undergoing bone marrow transplantation--a double-blind randomized control studyC Clerici, K D Setchell, N O'Connell, et al.
Bone Marrow Transplantation|December 17, 2008
Bleeding events and mortality in SCT patients: a retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHDE Holler, H J Kolb, H Greinix, et al.
The Cancer Journal From Scientific American|November 1, 1996
Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patientsC Aristei, F Aversa, C Raymondi, et al.
Bone Marrow Transplantation|May 28, 2013
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational studyC Aristei, A Santucci, R Corvò, et al.
Leukemia|December 27, 2013
Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myelomaR Silbermann, M Bolzoni, P Storti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemiaF Aversa, A Terenzi, A Carotti, et al.
Oncogene|June 30, 2015
PML is required for telomere stability in non-neoplastic human cellsM Marchesini, R Matocci, L Tasselli, et al.
Oncogene|April 8, 2016
PML is required for telomere stability in non-neoplastic human cellsM Marchesini, R Matocci, L Tasselli, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Bone Marrow Transplantation|February 16, 1999
Mismatched T cell-depleted hematopoietic stem cell transplantation for children with high-risk acute leukemiaF Aversa, A Terenzi, R Felicini, et al.
The New England Journal of Medicine|October 22, 1998
Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotypeF Aversa, A Tabilio, A Velardi, et al.
The Italian Journal of Gastroenterology|May 1, 1996
Effect of ursodeoxycholic acid on hypertransaminasaemia and bile acid composition in patients undergoing bone marrow transplantation--a double-blind randomized control studyC Clerici, K D Setchell, N O'Connell, et al.
Bone Marrow Transplantation|December 17, 2008
Bleeding events and mortality in SCT patients: a retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHDE Holler, H J Kolb, H Greinix, et al.
The Cancer Journal From Scientific American|November 1, 1996
Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patientsC Aristei, F Aversa, C Raymondi, et al.
Bone Marrow Transplantation|May 28, 2013
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational studyC Aristei, A Santucci, R Corvò, et al.
Leukemia|December 27, 2013
Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myelomaR Silbermann, M Bolzoni, P Storti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemiaF Aversa, A Terenzi, A Carotti, et al.
Oncogene|June 30, 2015
PML is required for telomere stability in non-neoplastic human cellsM Marchesini, R Matocci, L Tasselli, et al.
Oncogene|April 8, 2016
PML is required for telomere stability in non-neoplastic human cellsM Marchesini, R Matocci, L Tasselli, et al.
Pageof 11